Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder-Reference-Cited by-同舟云学术

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

Published:2017-07 Issue: Volume:Volume 10 Page:209-215
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Zastrozhin Michael Sergeevich,Brodyansky Vadim,Skryabin Valentin,Grishina Elena,Ivashchenko Dmitry,Ryzhikova Kristina^ORCID,Savchenko Ludmila,Kibitov Alexander,Bryun Evgeny,Sychev Dmitriy

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders;Drug Metabolism and Personalized Therapy;2022-11-28

2. An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice;Frontiers in Pharmacology;2022-04-25

3. Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study;Pharmacogenetics and Genomics;2021-11-08

4. Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome;Journal of Pharmacy Practice;2021-02-24

5. Problems of integrating medical science, image and practical health care: focus on personalized medicine;Pharmacogenetics and Pharmacogenomics;2020-12-28